Crossmark

Blood Biomarkers from Research Use to Clinical Practice: What Must Be Done? A Report from the EU/US CTAD Task Force

Crossref DOI link: https://doi.org/10.14283/jpad.2022.85

Published Print: 2022-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Angioni, Davide

Delrieu, J.

Hansson, O.

Fillit, H.

Aisen, P.

Cummings, J.

Sims, J.R.

Braunstein, J.B.

Sabbagh, M.

Bittner, T.

Pontecorvo, M.

Bozeat, S.

Dage, J.L.

Largent, E.

Mattke, S.

Correa, O.

Gutierrez Robledo, L.M.

Baldivieso, V.

Willis, D.R.

Atri, A.

Bateman, R.J.

Ousset, P.-J.

Vellas, B.

Weiner, M.
License Information

Text and Data Mining valid from 2022-10-01

Text and Data Mining valid from 2022-10-01

Version of Record valid from 2022-10-12
More Information

This article is maintained by: Elsevier

Article Title: Blood Biomarkers from Research Use to Clinical Practice: What Must Be Done? A Report from the EU/US CTAD Task Force

Journal Title: The Journal of Prevention of Alzheimer's Disease

CrossRef DOI link to publisher maintained version: https://doi.org/10.14283/jpad.2022.85

Content Type: article

Copyright: Copyright © 2022 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS